A special issue of Hepatoma Research
ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)
Submission deadline: 30 Nov 2020
Liver Transplantation is now an established therapy for patients with known Hepatocellular Carcinoma (HCC). Criteria for patient selection vary across several countries and continents ranging from the well established Milan criteria to University of San Francisco California Criteria and the more recently modified criteria such as the Metro ticket concept designed to include serum alpha-fetoprotein levels and hence aspects of tumour biology in patient selection. HCC is a complication of all forms of cirrhosis and continues to be a significant problem in patients with chronic HCV-associated cirrhosis even in those who have cleared the virus .With the emergence of non-alcoholic liver disease as an increasing cause of HCC and an indication for liver transplantation, post-transplant metabolic issues in HCC patients need to be monitored and addressed. Hepatitis B virus-associated HCC means that prevention of HBV recurrence is a major issue for HCC patients undergoing liver transplantation in many parts of the world .HCC also complicates autoimmune disease such as Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis.Hence, recurrence of these diseases may also pose a problem in liver transplantation for HCC. All these issues are addressed in this issue by international leading experts.In addition, common problems that effect all patients such as early allograft dysfunction, allograft rejection, acute kidney injury as well as long term problems such as ischemic biliopathy and extrahepatic malignancy in long-term immunosuppressed patients are discussed. Hence, this issue covers all the major topics that need to be understood in managing patients with HCC undergoing liver transplantation.
1.Primary non-function and Early allograft dysfunction
2.Acute kidney injury: Prevention and effect on immunosuppression
3.Acute allograft rejection: Diagnosis, risk factors and treatment
4.Prevention of HBV recurrence
5.Minimisation of HCC recurrence and treatment
1.Ischemic Biliopathy: Risk factors and management
2.Extrahepatic malignancy: Risks and prevention
3.Recognition and management of the metabollic syndrome
4.Recurrent Autoimmune diseases(PBC/PSC/AIH)
1. Ming-Ling Chang Division of Hepatology, Department of Gastroenterology and Hepatology, Liver Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
2. Michal Grat Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
3. Andrew L Mason Division of Gastroenterology and Hepatology, University of Alberta, Edmonton, Alberta, Canada.
4. James Fung Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
5. Claire Vajdic Centre for Big Data Research in Health, University of New South Wales, Kensington, NSW, Australia.
6. Stephen J. Wigmore Department of HPB/Transplant Surgery, Royal Infirmary of Edinburgh, The University of Edinburgh, Edinburgh, UK.
7. Michele Molinari Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
8. Kamleshsingh Shadhu Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University & Jiangsu Province Hospital, Nanjing, Jiangsu, China.
9. Eguchi, Susumu Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
10. Hajime Matsushima Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
11. Andrew J. Muir Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
12. Łukasz Masior Department of General, Vascular and Oncological Surgery, Medical University of Warsaw, Warsaw, Poland.
13. Anthony Michaels Department of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
14. Coleman I Smith MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC, USA.
15. Luciana Costa Faria Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.
16. Michael Ronan Lucey Division of Gastroenterology and Hepatology, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.
17. Parul D Agarwal Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
18. Mohamed Rela MS Dr. Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India.
19. Aiwu Ruth He Lombardi Cancer Center, Georgetown University School of Medicine, Washington, DC, USA.
20. Oya M. Andacoglu Abdominal Transplant Surgeon, Koc University, Live Donor Liver Transplantation Unit, Istanbul, Turkey.
21. Ryan A. Helmick Division of Transplant Surgery, Methodist University Hospital Transplant Institute, Memphis, TN, USA.
The list is arranged in no particular order and being updated.
Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://hrjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/HR/?IssueId=470
Submission Deadline: 30 Nov 2020
Contacts: Ada Zhong, Assistant Editor, editor_Ada@hrjournal.net